Bank of Montreal
TARS icon

Bank of Montreal’s Tarsus Pharmaceuticals TARS Stock Holding History

Bank of Montreal’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-192
Closed -$5K – 4831
2021
Q1 		$5K Sell
192
-773
-80% -$28.6K ﹤0.01% 4667
2020
Q4 		$43K Buy
+965
New +$27.5K ﹤0.01% 4034

Other funds holding TARS

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal's TARS Position: Q2 2021 in Review

Bank of Montreal sold out of Tarsus Pharmaceuticals (TARS) in Q2 2021, closing a stake of 192 shares — an estimated $5K sold.

Bank of Montreal first reported a position in TARS in Q4 2020 and held it in 2 quarters. The position peaked at $43K in Q4 2020. 44 funds tracked by Wall St. Rank hold TARS as of Q2 2021.

  • Bank of Montreal reported no remaining Tarsus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 192 Tarsus Pharmaceuticals shares in Q2 2021, an estimated $5K.
  • Bank of Montreal first reported a position in Tarsus Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Bank of Montreal's Tarsus Pharmaceuticals position peaked at $43K in Q4 2020.
  • 44 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.